Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

[Quality of life of patients before and after surgical treatment of diffuse toxic goiter].

Il'icheva EA, Zudaev VP, Roĭ TA, Makhutov VN, Tarnueva IF, Moshkova ES.

Vestn Khir Im I I Grek. 2011;170(4):58-63. Russian.

PMID:
22191260
2.

Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials.

Porta M, Hainer JW, Jansson SO, Malm A, Bilous R, Chaturvedi N, Fuller JH, Klein R, Orchard T, Parving HH, Sjølie AK; DIRECT Study Group..

Diabetologia. 2011 Jun;54(6):1298-303. doi: 10.1007/s00125-010-2040-1.

PMID:
21225239
3.

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.

Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, Bilous R, Chaturvedi N; DIRECT Programme Study Group..

Lancet. 2008 Oct 18;372(9647):1385-93. doi: 10.1016/S0140-6736(08)61411-7.

4.

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.

Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, Parving HH, Bilous R, Sjølie AK; DIRECT Programme Study Group..

Lancet. 2008 Oct 18;372(9647):1394-402. doi: 10.1016/S0140-6736(08)61412-9.

PMID:
18823656

Supplemental Content

Loading ...
Support Center